Pathogenese der Psoriasis vulgaris

Psoriasis is an inflammatory T cell-mediated autoimmune disease of skin and joints that affects 2-4 % of the adult population and 0.1-1 % of children. Genetic susceptibility, environmental triggering factors, and innate immune processes initiate psoriasis pathogenesis that results in an adaptive aut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schäkel, Knut (VerfasserIn) , Schön, Michael (VerfasserIn) , Ghoreschi, Kamran (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Veröffentlicht: 31. Mai 2016
In: Der Hautarzt
Year: 2016, Jahrgang: 67, Heft: 6, Pages: 422-431
ISSN:1432-1173
DOI:10.1007/s00105-016-3800-8
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00105-016-3800-8
Volltext
Verfasserangaben:K. Schäkel, M.P. Schön, K. Ghoreschi
Beschreibung
Zusammenfassung:Psoriasis is an inflammatory T cell-mediated autoimmune disease of skin and joints that affects 2-4 % of the adult population and 0.1-1 % of children. Genetic susceptibility, environmental triggering factors, and innate immune processes initiate psoriasis pathogenesis that results in an adaptive autoreactive response. The T cell response is orchestrated by CD 8+ T cells in the epidermis and by CD 4+ T cells in the dermis that predominantly produce interleukin-17 (IL‑17). Research of the past 15 years unraveled cellular and molecular mechanisms as well as cytokines like TNF-α or IL‑23 that contribute to psoriatic inflammation. This knowledge has been translated into clinical practice and a number of antipsoriatic small molecules and immunobiologics are now available. Here, we discuss the current principles of psoriasis pathogenesis in the context of modern therapies.
Beschreibung:Gesehen am 08.08.2019
Beschreibung:Online Resource
ISSN:1432-1173
DOI:10.1007/s00105-016-3800-8